SK hynix Inc. enters the final stretch of September having dropped 5.7% on the week to ₩1,690,000 — a reversal that stands out less because of anything specific to the company and more because the broader memory and semiconductor complex has turned sharply lower together.
The positioning picture, however, tells a story that is notably detached from the price action. Borrow availability is essentially infinite — running at the data ceiling of 9,999%, with 167.5 million shares still available to lend. That is the loosest it has been all quarter. Availability had briefly tightened into early September, touching around 6,600% on September 4 before relaxing again — a signal that short sellers made a modest push and then stepped back. The short score has barely moved this week, easing fractionally from 25.84 to 25.69 over the past ten days. That score ranks in the 96th percentile favourably — meaning shorts are among the lightest of any stock in the universe. Cost to borrow has drifted higher, up 26% on the week to 0.89%, but remains well within "low" territory. The overall read is that the lending market is exceptionally relaxed: there is no squeeze pressure, no crowded short, and no evidence of forced covering activity on the Korean listing.
The Street's positioning is broadly constructive. The analyst consensus mean price target of ₩3,202,944 implies roughly 90% upside from current levels — a gap that reflects how far the stock has sold off from peak valuations rather than a sudden surge in bullishness, and the target should be read with that context in mind. Factor scores paint a similarly positive picture: the analyst recommendation differential ranks in the 96th percentile, the EV/EBIT rank sits at 97th, and days-to-cover ranks at the 90th percentile. EPS surprise scores at the 82nd percentile, consistent with SK Hynix's recent history of beating estimates. The one genuine blemish in the scoring is the 12-month forward EPS year-on-year growth factor, which ranks at just the 11th percentile — reflecting a market already pricing in a steep earnings deceleration from the cycle peaks. At current multiples the stock trades at a PE of around 3.9x and an EV/EBITDA of roughly 3x, both of which have compressed materially over the past 30 days as the price has weakened.
Institutional ownership offers an interesting counterpoint to the short-term weakness. SK Square holds 20% as the strategic anchor. BlackRock added 1.6 million shares as of August 31. Capital Research and Franklin Templeton also added positions through the same period. The net direction among the largest foreign holders has been to buy, not to trim — a contrast with the stock's 5.7% weekly decline. The insider picture is less clear-cut. A group of independent directors received small share grants in late August. The more notable entry is a 600-share open-market sale by a Group Director at ₩1,760,000 per share on August 20 — the highest-priced trade in the recent history, and now underwater given the current price. Net shares over 90 days are marginally positive, but net value is negative due to that sale.
The most recent earnings print, on July 29, produced a sharp initial reaction: the stock fell 14.7% on the day, only to recover 7.6% over the following five sessions. That whipsaw pattern is worth noting as Q3 results approach on October 29. The memory cycle and the AI infrastructure build-out remain the two variables that will dominate any earnings debate — how the market frames the demand trajectory into year-end will matter far more than any single quarter's beat or miss. Meanwhile, the peer complex is offering no comfort this week: MU fell 7.3% over the same period and MKSI dropped 12.8%, suggesting the weakness in SK Hynix's Korean listing is part of a broader sector de-rating rather than a company-specific development. October 29 is the next hard date on the calendar.
See the live data behind this article on ORTEX.
Open A000660 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
